A detailed history of Paragon Financial Partners, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Paragon Financial Partners, Inc. holds 228 shares of LLY stock, worth $175,049. This represents 0.15% of its overall portfolio holdings.

Number of Shares
228
Previous 228 -0.0%
Holding current value
$175,049
Previous $206,000 2.43%
% of portfolio
0.15%
Previous 0.16%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$724.87 - $909.04 $165,270 - $207,261
228 New
228 $206,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Paragon Financial Partners, Inc. Portfolio

Follow Paragon Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paragon Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Paragon Financial Partners, Inc. with notifications on news.